Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development

Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and ...
Business Wire

Cellino Invited to Speak at Keystone Symposia Conference Marking the 20th Anniversary of iPSC Discovery in Kyoto, Japan

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced that the company has been invited to ...
News Medical

2024 is shaping up to be “the year of iPSCs"

We’ve seen a real shift in the industry towards in vitro technology, with strong headwinds coming from key places including the US, Japan and Europe. From the top level, the iPSC market is growing at ...
Morningstar

Cellino Invited to Speak at Keystone Symposia Conference Marking the 20th Anniversary of iPSC Discovery in Kyoto, Japan

Meeting co-organized by Nobel Laureate Dr. Shinya Yamanaka, discoverer of induced pluripotent stem cells, Yanhong Shi, Ph.D., and Yasushi Kajii, Ph.D. Cellino, a regenerative medicine company ...